|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: CRESTOR
Summary for Tradename: CRESTOR
|
|
Latest news for CRESTORSome statin drugs do seem to raise users' risk of diabetes, study suggests23 May 2013, 8:09 pm You Should Consider Quality of Life When Evaluating Medication Use21 May 2013, 10:14 am Roach: Balance meds, quality of life21 May 2013, 3:47 am Balance meds with the quality of life21 May 2013, 3:37 am Dr. Roach: Life quality should balance medicine use20 May 2013, 10:41 pm Merck's Cholesterol Pill Win Is Already Drawing Fire3 May 2013, 6:03 pm AstraZeneca hit by generic drugs and Crestor shortfall25 April 2013, 6:12 am UPDATE 2-AstraZeneca hit by generic drugs and Crestor shortfall25 April 2013, 6:10 am AstraZeneca first-quarter sales tumble as generic losses bite deep25 April 2013, 2:34 am Courtesy of Yahoo News | ||||||||||||
Clinical Trials for: CRESTORA Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139) Status: Completed Condition: Hypercholesterolemia The Rosuvastatin In TrAnsplant Recipients Study Status: Completed Condition: Disorder Related to Renal Transplantation; Hypercholesterolemia 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease Status: Completed Condition: Dyslipidemia; Kidney Disease Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan Status: Completed Condition: Hypertension; Hyperlipidemia A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers Status: Completed Condition: Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg Status: Completed Condition: Hypercholesterolemia; Coronary Heart Disease; Atherosclerosis To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers Status: Completed Condition: Atherosclerosis Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome Status: Completed Condition: Metabolic Syndrome A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia Status: Completed Condition: Hypercholesterolemia; Dyslipidemia Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study Status: Active, not recruiting Condition: HIV Infections Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ipr | CRESTOR | rosuvastatin calcium | TABLET; ORAL | 021366 | Aug 12, 2003 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ipr | CRESTOR | rosuvastatin calcium | TABLET; ORAL | 021366 | Aug 12, 2003 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ipr | CRESTOR | rosuvastatin calcium | TABLET; ORAL | 021366 | Aug 12, 2003 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ipr | CRESTOR | rosuvastatin calcium | TABLET; ORAL | 021366 | Aug 12, 2003 | RX | No | 6,316,460*PED | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Paragraph IV activity for: CRESTOR
| Drugname | Dosage | Strength | RLD | Submissiondate |
| rosuvastatin calcium | Tablets | 5 mg, 10 mg, 20 mg and 40 mg | Crestor | 8/13/2007 |
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc